Replication of lentiviruses

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Acheampong, Edward ^a   Rosario Otero, Miguel ^a   Dornburg, Ralph ^a   Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

HIV 1; Lentivirus; Replication; Review; Virus

Indexed keywords

PROTEIN DERIVATIVE; VIRUS PROTEIN;

CELL CYCLE; CONFORMATIONAL TRANSITION; DNA SYNTHESIS; ENVELOPE GENE; GENETIC CODE; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MICROMORPHOLOGY; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION; REVIEW; RNA SPLICING; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; HUMAN; PHYSIOLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

ANIMALS; HUMANS; LENTIVIRUS; VIRUS REPLICATION;

EID: 3142751409     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (194)

1. Coffin J. M.: Retroviridiae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, and Roizman B eds. Fields Virology. 3rd Ed., 1996:1767-1847 (1996)
2. Tang H., K. L. Kuhen & F. Wong-Staal: Lentivirus replication and regulation. Annu Rev Genet 33, 133-170 (1999)
3. Weiss R. A.: Retrovirus classification and cell interactions. J Antimicrob Chemother 37 Suppl B, 1-11 (1996)
4. Valee H. C. H.: Sur la nature infectieuse de l'anemie du cheval. CR Acad Sci 139, 331-333 (1994)
5. Clements J. E. & M. C. Zink: Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev 9, 100-117 (1996)
6. Hirsch V. M., G. Dapolito, R. Goeken & B. J. Campbell: Phylogeny and natural history of the primate lentiviruses, SIV and HIV. Curr Opin Genet Dev 5, 798-806 (1995)
7. Hsiung G. D.: Perspectives of retroviruses and etiologic agents of AIDS. The Yale Journal of Biology and Medicine. 60, 505-514 (1987)
8. Jones K. A. & B. M. Peterlin: Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63, 717-743 (1994)
9. Takahashi I., M. Takama, A. M. Ladhoff & D. Scholz: Envelope structure model of human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 2, 136-140 (1989)
10. Nermut M. V., C. Grief & Sea, A. R. & H. R.-.Hashmi: Further evidence of icosahedral symmetry in human and simian immunodeficiency virus. AIDS Res Hum Retroviruses 9, 929-938 (1993)
11. Marx P. A., R. J. Munn & K. I. Joy: Computer emulation of thin section electron microscopy predicts an envelope-associated icosadeltahedral capsid for human immunodeficiency virus. Lab Invest 58, 112-118 (1988)
12. Cullen B. R. & W. C. Greene: Functions of the auxiliary gene products of the human immunodeficiency virus type 1. Virology 178, 1-5 (1990)
13. Schwartz S., B. K. Felber, D. M. Benko, E. M. Fenyo & G. N. Pavlakis: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 64, 2519-2529 (1990)
14. Desrosiers R. C.: The simian immunodeficiency viruses. Annu Rev Immunol 8, 557-578 (1990)
15. Franchini G., C. Gurgo, H. G. Guo, R. C. Gallo, E. Collalti, K. A. Fargnoli, L. F. Hall, F. Wong-Staal & M. S. Reitz, Jr.: Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses. Nature 328, 539-543 (1987)
16. Willey R. L., F. Maldarelli, M. A. Martin & K. Strebel: Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 66, 7193-7200 (1992)
17. Willey R. L., F. Maldarelli, M. A. Martin & K. Strebel: Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol 66, 226-234 (1992)
18. Foti M., A. Mangasarian, V. Piguet, D. P. Lew, K. H. Krause, D. Trono & J. L. Carpentier: Nef-mediated clathrin-coated pit formation. J Cell Biol 139, 37-47 (1997)
19. Le Gall S., L. Erdtmann, S. Benichou, C. Berlioz-Torrent, L. Liu, R. Benarous, J. M. Heard & O. Schwartz: Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495 (1998)
20. Xu X. N., B. Laffert, G. R. Screaton, M. Kraft, D. Wolf, W. Kolanus, J. Mongkolsapay, A. J. McMichael & A. S. Baur: Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med 189, 1489-1496 (1999)
21. Li C. J., D. J. Friedman, C. Wang, V. Metelev & A. B. Pardee: Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268, 429-431 (1995)
22. Nath A. & J. Geiger: Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 54, 19-33 (1998)
23. New D. R., M. Ma, L. G. Epstein, A. Nath & H. A. Gelbard: Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 3, 168-173 (1997)
24. Starcich B. R., B. H. Hahn, G. M. Shaw, P. D. McNeely, S. Modrow, H. Wolf, E. S. Parks, W. P. Parks, S. F. Josephs, R. C. Gallo & et al.: Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45, 637-648 (1986)
25. Speck R. F., K. Wehrly, E. J. Platt, R. E. Atchison, I. F. Charo, D. Kabat, B. Chesebro & M. A. Goldsmith: Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol 71, 7136-7139 (1997)
26. Dalgleish A. G., P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves & R. A. Weiss: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767 (1984)
27. Merigan T. C. J., J. G. Barlett & D. I. Bolognesi: n Textbook of AIDS Medicine. Second Ed. Williams & Wilkins, Eds. (1999)
28. Cocchi F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo & P. Lusso: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815 (1995)
29. Feng Y., C. C. Broder, P. E. Kennedy & E. A. Berger: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996)
30. Zhang L., Y. Huang, T. He, Y. Cao & D. D. Ho: HIV-1 subtype and second-receptor use. Nature 383, 768 (1996)
31. Alkhatib G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy & E. A. Berger: CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996)
32. Choe H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard & J. Sodroski: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996)
33. Deng H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman & N. R. Landau: Identification of a major coreceptor for primary isolates of HIV-1. Nature 381, 661-666 (1996)
34. Doranz B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman & R. W. Doms: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996)
35. Dragic T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore & W. A. Paxton: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673 (1996)
36. Simmons G., D. Wilkinson, J. D. Reeves, M. T. Dittmar, S. Beddows, J. Weber, G. Carnegie, U. Desselberger, P. W. Gray, R. A. Weiss & P. R. Clapham: Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 70, 8355-8360 (1996)
37. McKnight A., D. Wilkinson, G. Simmons, S. Talbot, L. Picard, M. Ahuja, M. Marsh, J. A. Hoxie & P. R. Clapham: Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 71, 1692-1696 (1997)
38. Berger E. A.: HIV entry and tropism: the chemokine receptor connection. AIDS 11 Suppl A, S3-16 (1997)
39. Moore J. P.: Coreceptors: implications for HIV pathogenesis and therapy. Science 276, 51-52 (1997)
40. Wyatt R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson & J. G. Sodroski: The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711 (1998)
41. Kwong P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski & W. A. Hendrickson: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659 (1998)
42. Skalka A. M. & P. S. Golf: Reverse transcriptase. Cold Spring Harbor Laboratory Press 1-492 (1993)
43. Coffin J. M. & W. A. Haseltine: Terminal redundancy and the origin of replication of Rous sarcoma virus RNA. Proc Natl Acad Sci USA 74, 1908-1912 (1977)
44. Jiang M., J. Mak, A. Ladha, E. Cohen, M. Klein, B. Rovinski & L. Kleiman: Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol 67, 3246-3253 (1993)
45. Champoux J.: Roles of RNase H in reverse transcription. In: A Skalka, Cold Spring Harbor Laboratory Press 103-118 (1993)
46. Fu T. B. & J. Taylor: When retroviral reverse transcriptases reach the end of their RNA templates. J Virol 66, 4271-4278 (1992)
47. Gopalakrishnan V., J. A. Peliska & S. J. Benkovic: Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. Proc Natl Acad Sci USA 89, 10763-10767 (1992)
48. Finston W. I. J. & J. Champoux: RNA-primed initiation of Moloney murine leukemia virus plus strands by reverse transcriptase in vitro. J Virol 51, 26-33 (1984)
49. Fujiwara T. & K. Mizuuchi: Retroviral DNA integration: structure of an integration intermediate. Cell 54, 497-504 (1988)
50. Huber H. E. C. & C. Richardson: Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase. J Biol Chem 265, 10565-10573 (1990)
51. Charneau P., M. Alizon & F. Clavel: A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol 66, 2814-2820 (1992)
52. Gilboa E., S. W. Mitra, S. Goff & D. Baltimore: A detailed model of reverse transcription and tests of crucial aspects. Cell 18, 93-100 (1979)
53. Bushman F. D., T. Fujiwara & R. Craigie: Retroviral DNA integration directed by HIV integration protein in vitro. Science 249, 1555-1558 (1990)
54. Grandgenett D. P. S. R. Mumm: Unraveling retrovirus integration. Cell 60, 3-4 (1990)
55. Gallay P., S. Swingler, J. Song, F. Bushman & D. Trono: HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83, 569-576 (1995)
56. Heinzinger N. K., M. I. Bukinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M. A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson & M. Emerman: The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 91, 7311-7315 (1994)
57. Bukrinsky M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman & M. Stevenson: A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666-669 (1993)
58. Gorlich D., S. Kostka, R. Kraft, C. Dingwall, R. A. Laskey, E. Hartmann & S. Prehn: Two different subunits of importin cooperate to recognize nuclear localization signals and bind them to the nuclear envelope. Curr Biol 5, 383-392 (1995)
59. Gallay P., T. Hope, D. Chin & D. Trono: HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci USA 94, 9825-9830 (1997)
60. Imamoto N., T. Tachibana, M. Matsubae & Y. Yoneda: A karyophilic protein forms a stable complex with cytoplasmic components prior to nuclear pore binding. J Biol Chem 270, 8559-8565 (1995)
61. Adam S. & A. L. Gerace: Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import. Cell 66, 837-847 (1991)
62. Weis K., I. W. Mattaj & A. I. Lamond: Identification of hSRP1 alpha as a functional receptor for nuclear localization sequences. Science 268, 1049-1053 (1995)
63. Fouchier R. A., B. E. Meyer, J. H. Simon, U. Fischer & M. H. Malim: HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J 16, 4531-4539 (1997)
64. Freed E. O. & M. A. Martin: HIV-1 infection of non-dividing cells. Nature 369, 107-108 (1994)
65. Freed E. O., G. Englund & M. A. Martin: Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 69, 3949-3954 (1995)
66. Bukrinsky M. I. & O. K. Haffar: HIV-1 nuclear import: in search of a leader. Front Biosci 4, D772-781 (1999)
67. Miller M. D., C. M. Farnet & F. D. Bushman: Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 71, 5382-5390 (1997)
68. Popov S., M. Rexach, G. Zybarth, N. Reiling, M. A. Lee, L. Ratner, C. M. Lane, M. S. Moore, G. Blobel & M. Bukrinsky: Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J 17, 909-917 (1998)
69. Vodicka M. A., D. M. Koepp, P. A. Silver & M. Emerman: HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 12, 175-185 (1998)
70. Brown P. O., B. Bowerman, H. E. Varmus & J. M. Bishop: Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc Natl Acad Sci USA 86, 2525-2529 (1989)
71. Barr P. J., O. B. Mason, K. E. Landsberg, P. A. Wong, M. C. Kiefer & A. J. Brake: cDNA and gene structure for a human subtilisin-like protease with cleavage specificity for paired basic amino acid residues. DNA Cell Biol 10, 319-328 (1991)
72. Duker N. J. & C. L. Grant: Alterations in the levels of deoxyuridine triphosphatase, uracil-DNA glycosylase and AP endonuclease during the cell cycle. Exp Cell Res 125, 493-497 (1980)
73. Franza B. R., Jr., S. F. Josephs, M. Z. Gilman, W. Ryan & B. Clarkson: Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay. Nature 330, 391-395 (1987)
74. Garcia J. A., F. K. Wu, R. Mitsuyasu & R. B. Gaynor: Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J 6, 3761-3770 (1987)
75. Jones K. A., J. T. Kadonaga, P. A. Luciw & R. Tjian: Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232, 755-759 (1986)
76. Jones J. S., R. W. Allan & H. M. Temin: One retroviral RNA is sufficient for synthesis of viral DNA. J Virol 68, 207-216 (1994)
77. Karn J., M. J. Churcher, K. Rittner, N. J. Keen & M. J. Gait: Control of transcriptional elongation by the human immunodeficiency virus Tat protein. In: Eukaryotic Gene Transcription, Ed: Goodbourn, S. Oxford University Press, Oxford, (1996)
78. Gabuzda D. H., J. L. Hess, J. A. Small & J. E. Clements: Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Molec Cell Mol 9, 2728-2733 (1989)
79. Hess J. L., J. A. Small & J. E. Clements: Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and transactivation. J Virol 63, 3001-3015 (1989)
80. Elder J. H., D. L. Lerner, C. S. Hasselkus-Light, D. J. Fontenot, E. Hunter, P. A. Luciw, R. C. Montelaro & T. R. Phillips: Distinct subsets of retro viruses encode dUTPase. J Virol 66, 1791-1794 (1992)
81. Arya S. K.: Human and simian immunodeficiency retro viruses: activation and differential transactivation of gene expression. AIDS Res Hum Retroviruses 4, 175-186 (1988)
82. Arya S. K. & R. C. Gallo: Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements. Proc Natl Acad Sci USA 85, 9753-9757 (1988)
83. Muesing M. A., D. H. Smith & D. J. Capon: Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48, 691-701 (1987)
84. Braun M. J., J. E. Clements & M. A. Gonda: The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. J Virol 61, 4046-4054 (1987)
85. Saltarelli M., G. Querat, D. A. Konings, R. Vigne & J. E. Clements: Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virol 179, 347-364 (1990)
86. Ahmed Y. F., G. M. Gilmartin, S. M. Hanly, J. R. Nevins & W. C. Greene: The HTLV-I Rex response element mediates a novel form of mRNA polyadenylation. Cell 64, 727-737 (1991)
87. Arrigo S. J. & I. S. Chen: Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev 5, 808-819 (1991)
88. Cochrane A. W., C. H. Chen & C. A. Rosen: Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc Natl Acad Sci USA 87, 1198-1202 (1990)
89. Malim M. H., J. Hauber, S. Y. Le, J. V. Maizel & B. R. Cullen: The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257 (1989)
90. Olsen H. S., A. W. Cochrane, P. J. Dillon, C. M. Nalin & C. A. Rosen: Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev 4, 1357-1364 (1990)
91. Cullen B. R.: Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev 56, 375-394 (1992)
92. Hunter E.: Macromolecular interactions in the assembly of HIV and other retroviruses. Seminars in Virology 5, 71-83 (1994)
93. Rhee S. S. & E. Hunter: Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid. EMBO J 10, 535-546 (1991)
94. Fine D. & G. Schochetman: Type D primate retroviruses: a review. Cancer Res 38, 3123-3139 (1978)
95. Rhee S. S., H. X. Hui & E. Hunter: Preassembled capsids of type D retroviruses contain a signal sufficient for targeting specifically to the plasma membrane. J Virol 64, 3844-3852 (1990)
96. Jones T. A., G. Blaug, M. Hansen & E. Barklis: Assembly of gag-beta-galactosidase proteins into retrovirus particles. J Virol, 64, 2265-2279 (1990)
97. Teich N.: Taxonomy of retroviruses. In: RNA Tumor Viruses (Weiss A., Teich, N., Varmus, H.E., Coffin, J.M. eds) Cold Spring Harbor Laboratory, 25-207 (1991)
98. Hansen M., L. Jelinek, S. Whiting & E. Barklis: Transport and assembly of gag proteins into Moloney murine leukemia virus. J Virol 64, 5306-5316 (1990)
99. Rein A., M. R. McClure, N. R. Rice, R. B. Luftig & A. M. Schultz: Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci USA 83, 7246-7250 (1986)
100. Craven R. C., R. P. Bennett & J. W. Wills: Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly. J Virol, 65, 6205-6217 (1991)
101. Krausslich H. & G. R. Welker: Intracellular transport of retroviral capsid components. Curr Top Microbiol Immunol 214, 25-63 (1996)
102. Jewell N. A. & L. M. Mansky: In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J Gen Virol, 81, 1889-1899 (2000)
103. Jacks T.: Translational suppression in gene expression in retroviruses and retrotransposons. Curr Top Microbiol Immunol 157, 93-124 (1990)
104. Swanstrom R. & J. W. Willis: Synthesis, assembly and processing of viral proteins. In: Retroviruses, Edt Coffin, J.M., Hughes, S.H., Varmus, H.E. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, (1997)
105. Hatfield D. L., J. G. Levin, A. Rein & S. Oroszlan: Translational suppression in retroviral gene expression. Adv Virus Res 41, 193-239 (1992)
106. Park J. C. & D. Morrow: The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles. J Virol 66, 6304-6313 (1992)
107. Freed E. O.: HIV-1 gag proteins: diverse functions in the virus life cycle. Virol 251, 1-15 (1998)
108. McBride M. S. & A. T. Panganiban: Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo. J Virol 71, 2050-2058 (1997)
109. Harrison G. P., G. Miele, E. Hunter & A. M. Lever: Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line. J Virol 72, 5886-5896 (1998)
110. Luban J. S. & P. Goff: Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J Virol 68, 3784-3793 (1994)
111. Lever A., H. Gottlinger, W. Haseltine & J. Sodroski: Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol 63, 4085-4087 (1989)
112. Katz R. A., R. W. Terry & A. M. Skalka: A conserved cis-acting sequence in the 5′ leader of avian sarcoma virus RNA is required for packaging. J Virol 59, 163-167 (1986)
113. Watanabe S. H. & M. Temin: Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc Natl Acad Sci USA 79, 5986-5990 (1982)
114. Platt E. J. O. & K. Haffar: Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain. Proc Natl Acad Sci USA 91, 4594-4598 (1994)
115. Yu X. F., Z. Matsuda, Q. C. Yu, T. H. Lee & M. Essex: Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation. J Gen Virol 76 (Pt 12), 3171-3179 (1995)
116. Cimarelli A., S. Sandin, S. Hoglund & J. Luban: Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J Virol 74, 3046-3057 (2000)
117. Darlix J. L., C. Gabus, M. T. Nugeyre, F. Clavel & F. Barre-Sinoussi: Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Molec Biol 216, 689-699 (1990)
118. von Schwedler U., J. Song, C. Aiken & D. Trono: Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol 67, 4945-4955 (1993)
119. Aldrovandi G. M. & J. A. Zack: Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J Virol, 70, 1505-1511 (1996)
120. Desrosiers R. C., J. D. Lifson, J. S. Gibbs, S. C. Czajak, A. Y. Howe, L. O. Arthur & R. P. Johnson: Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol 72, 1431-1437 (1998)
121. Fisher A. G., B. Ensoli, L. Ivanoff, M. Chamberlain, S. Petteway, L. Ratner, R. C. Gallo & F. Wong-Staal: The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237, 888-893 (1987)
122. Gabuzda D. H., K. Lawrence, E. Langhoff, E. Terwilliger, T. Dorfman, W. A. Haseltine & J. Sodroski: Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol 66, 6489-6495 (1992)
123. Gabuzda D. H., H. Li, K. Lawrence, B. S. Vasir, K. Crawford & E. Langhoff: Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J Acquir Immune Defic Syndr 7, 908-915 (1994)
124. Strebel K., D. Daugherty, K. Clouse, D. Cohen, T. Folks & M. A. Martin: The HIV 'A' (sor) gene product is essential for virus infectivity. Nature 328, 728-730 (1987)
125. Simon J. H., D. L. Miller, R. A. Fouchier & M. H. Malim: Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function. Virol 248, 182-187 (1998)
126. Camaur D. & D. Trono: Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J Virol 70, 6106-6111 (1996)
127. Dettenhofer M., S. Cen, B. A. Carlson, L. Kleiman & X. F. Yu: Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J Virol 74, 8938-8945 (2000)
128. Simon J. H. & M. H. Malim: The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J Virol 70, 5297-5305 (1996)
129. Goncalves J., P. Jallepalli & D. H. Gabuzda: Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J Virol 68, 704-712 (1994)
130. Courcoul M., C. Patience, F. Rey, D. Blanc, A. Harmache, J. Sire, R. Vigne & B. Spire: Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J Virol 69, 2068-2074 (1995)
131. Simon J. H., R. A. Fouchier, T. E. Southerling, C. B. Guerra, C. K. Grant & M. H. Malim: The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J Virol 71, 5259-5267 (1997)
132. Hoglund S., A. Ohagen, K. Lawrence & D. Gabuzda: Role of vif during packing of the core of HIV-1. Virol 201, 349-355 (1994)
133. Hoglund S., L. G. Ofverstedt, A. Nilsson, P. Lundquist, H. Gelderblom, M. Ozel & U. Skoglund: Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res Hum Retroviruses 8, 1-7 (1992)
134. Guy B., M. Geist, K. Dott, D. Spehner, M. P. Kieny & J. P. Lecocq: A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol 65, 1325-1331 (1991)
135. Zhang H., R. J. Pomerantz, G. Dornadula & Y. Sun: Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J Virol 74, 8252-8261 (2000)
136. Dettenhofer M. & X. F. Yu: Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J Virol 73, 1460-1467 (1999)
137. Yang X. & D. Gabuzda: Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol 73, 3460-3466 (1999)
138. Yang X., J. Goncalves & D. Gabuzda: Phosphorylation of Vif and its role in HIV-1 replication. J Biol Chem 271, 10121-10129 (1996)
139. Yang X. & D. Gabuzda: Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein. J Biol Chem 273, 29879-29887 (1998)
140. Friedler A., N. Zakai, O. Karni, D. Friedler, C. Gilon & A. Loyter: Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein. J Molec Biol 289, 431-437 (1999)
141. Franchini G., M. Robert-Guroff, J. Ghrayeb, N. T. Chang & F. Wong-Staal: Cytoplasmic localization of the HTLV-III 3′ orf protein in cultured T cells. Virol 155, 593-599 (1986)
142. Anderson S., D. C. Shugars, R. Swanstrom & J. V. Garcia: Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J Virol 67, 4923-4931 (1993)
143. Niederman T. M., B. J. Thielan & L. Ratner: Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc Natl Acad Sci USA 86, 1128-1132 (1989)
144. Ahmad N. & S. Venkatesan: Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241, 1481-1485 (1988)
145. Miller M. D., M. T. Warmerdam, I. Gaston, W. C. Greene & M. B. Feinberg: The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 179, 101-113 (1994)
146. Cheng-Mayer C., P. Iannello, K. Shaw, P. A. Luciw & J. A. Levy: Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science 246, 1629-1632 (1989)
147. Bukrinsky M. I., T. L. Stanwick, M. P. Dempsey & M. Stevenson: Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427 (1991)
148. Zack J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip & I. S. Chen: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990)
149. Garcia J. V. & A. D. Miller: Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511 (1991)
150. Janeway C. A., Jr.: The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 10, 645-674 (1992)
151. Guy B., M. P. Kieny, Y. Riviere, C. Le Peuch, K. Dott, M. Girard, L. Montagnier & J. P. Lecocq: HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269 (1987)
152. Rhee S. S. & J. W. Marsh: Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J Virol 68, 5156-5163 (1994)
153. Sanfridson A., B. R. Cullen & C. Doyle: The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. J Biol Chem 269, 3917-3920 (1994)
154. Benson R. E., A. Sanfridson, J. S. Ottinger, C. Doyle & B. R. Cullen: Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med 177, 1561-1566 (1993)
155. Aiken C., J. Konner, N. R. Landau, M. E. Lenburg & D. Trono: Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864 (1994)
156. Bour S., C. Perrin & K. Strebel: Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. J Biol Chem 274, 33800-33806 (1999)
157. Stevenson M., C. Meier, A. M. Mann, N. Chapman & A. Wasiak: Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell 53, 483-496 (1988)
158. Aiken C. & D. Trono: Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 69, 5048-5056 (1995)
159. Bandres J. C. & L. Ratner: Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J Virol 68, 3243-3249 (1994)
160. Cullen B. R.: The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virol 205, 1-6 (1994)
161. Tsunetsugu-Yokota Y., S. Matsuda, M. Maekawa, T. Saito, T. Takemori & Y. Takebe: Constitutive expression of the nef gene suppresses human immunodeficiency virus type 1 (HIV-1) replication in monocytic cell lines. Virol 191, 960-963 (1992)
162. Baur A. S., E. T. Sawai, P. Dazin, W. J. Fantl, C. Cheng-Mayer & B. M. Peterlin: HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384 (1994)
163. De S. K. & J. W. Marsh: HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. J Biol Chem 269, 6656-6660 (1994)
164. Cohen E. A., E. F. Terwilliger, J. G. Sodroski & W. A. Haseltine: Identification of a protein encoded by the vpu gene of HIV-1. Nature 334, 532-534 (1988)
165. Subbramanian R. A. & E. A. Cohen: Molecular biology of the human immunodeficiency virus accessory proteins. J Virol 68, 6831-6835 (1994)
166. Dejucq N.: HIV-1 replication in CD4+ T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function. J Leukoc Biol 68, 331-337 (2000)
167. Balliet J. W., D. L. Kolson, G. Eiger, F. M. Kim, K. A. McGann, A. Srinivasan & R. Collman: Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virol 200, 623-631 (1994)
168. Kawamura M., T. Ishizaki, A. Ishimoto, T. Shioda, T. Kitamura & A. Adachi: Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. J Gen Virol 75 (Pt 9), 2427-2431 (1994)
169. Schubert U., L. C. Anton, I. Bacik, J. H. Cox, S. Bour, J. R. Bennink, M. Orlowski, K. Strebel & J. W. Yewdell: CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol 72, 2280-2288 (1998)
170. Friborg J., A. Ladha, H. Gottlinger, W. A. Haseltine & E. A. Cohen: Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J Acquir Immune Defic Syndr Hum Retrovirol 8, 10-22 (1995)
171. Schubert U., T. Schneider, P. Henklein, K. Hoffmann, E. Berthold, H. Hauser, G. Pauli & T. Porstmann: Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur J Biochem 204, 875-883 (1992)
172. Hrimech M., X. J. Yao, P. E. Branton & E. A. Cohen: Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. EMBO J 19, 3956-3967 (2000)
173. Bachand F., X. J. Yao, M. Hrimech, N. Rougeau & E. A. Cohen:
174. Selig L., J. C. Pages, V. Tanchou, S. Preveral, C. Berlioz-Torrent, L. X. Liu, L. Erdtmann, J. Darlix, R. Benarous & S. Benichou: Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J Virol 73, 592-600 (1999)
175. Paxton W., R. I. Connor & N. R. Landau: Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol 67, 7229-7237 (1993)
176. Nie Z., D. Bergeron, R. A. Subbramanian, X. J. Yao, F. Checroune, N. Rougeau & E. A. Cohen: The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J Virol 72, 4104-4115 (1998)
177. Fouchier R. A. & M. H. Malim: Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv Virus Res 52, 275-299 (1999)
178. Mahalingam S., R. G. Collman, M. Patel, C. E. Monken & A. Srinivasan: Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. Virol 212, 331-339 (1995)
179. Lu Y. L., P. Spearman & L. Ratner: Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol 67, 6542-6550 (1993)
180. He J., S. Choe, R. Walker, P. Di Marzio, D. O. Morgan & N. R. Landau: Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 69, 6705-6711 (1995)
181. Macreadie I. G., L. A. Castelli, D. R. Hewish, A. Kirkpatrick, A. C. Ward & A. A. Azad: A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci USA 92, 2770-2774 (1995)
182. Planelles V., J. B. Jowett, Q. X. Li, Y. Xie, B. Hahn & I. S. Chen: Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol 70, 2516-2524 (1996)
183. Rogel M. E., L. I. Wu & M. Emerman: The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol 69, 882-888 (1995)
184. Conti L., P. Matarrese, B. Varano, M. C. Gauzzi, A. Sato, W. Malorni, F. Belardelli & S. Gessani: Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells. J Immunol 165, 3293-3300 (2000)
185. Fukumori T., H. Akari, S. Iida, S. Hata, S. Kagawa, Y. Aida, A. H. Koyama & A. Adachi: The HIV-1 Vpr displays strong anti-apoptotic activity. FEBS Lett 432, 17-20 (1998)
186. Conti L., G. Rainaldi, P. Matarrese, B. Varano, R. Rivabene, S. Columba, A. Sato, F. Belardelli, W. Malorni & S. Gessani: The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J Exp Med 187, 403-413 (1998)
187. Mansky L. M., S. Preveral, L. Selig, R. Benarous & S. Benichou: The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate. J Virol 74, 7039-7047 (2000)
188. Mansky L. M.: The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene. Virol 222, 391-400 (1996)
189. Bouhamdan M., S. Benichou, F. Rey, J. M. Navarro, I. Agostini, B. Spire, J. Camonis, G. Slupphaug, R. Vigne, R. Benarous & J. Sire: Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol 70, 697-704 (1996)
190. Gragerov A., T. Kino, G. Ilyina-Gragerova, G. P. Chrousos & G. N. Pavlakis: HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. Virol 245, 323-330 (1998)
191. Withers-Ward E. S., J. B. Jowett, S. A. Stewart, Y. M. Xie, A. Garfinkel, Y. Shibagaki, S. A. Chow, N. Shah, F. Hanaoka, D. G. Sawitz, R. W. Armstrong, L. M. Souza & I. S. Chen: Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J Virol 71, 9732-9742 (1997)
192. Mansky L. M. & H. M. Temin: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69, 5087-5094 (1995)
193. Luciw P. A. & B. L. Shacklett: Molecular biology of the human and simian immunodeficiency viruses. In: HIV Molecular Organization, Pathogenicity and Treatment, Edt. Morrow, W.J.W. and Hagwood, N.L. Elsevier Science Publishers, BV, (1993)
194. Littman R. L: Chemokine receptors: Keys to aids pathogenesis? Cell 93, 677-680 (1998)